HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven T Pals Selected Research

B-Cell Antigen Receptors (B Cell Antigen Receptors)

1/2022A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways.
3/2012The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.
4/2005Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven T Pals Research Topics

Disease

17Neoplasms (Cancer)
01/2021 - 02/2002
13Multiple Myeloma
12/2021 - 02/2002
7Lymphoma (Lymphomas)
01/2022 - 01/2003
7Colorectal Neoplasms (Colorectal Cancer)
12/2020 - 09/2002
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2006
5Inflammation (Inflammations)
01/2019 - 02/2002
5Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2011 - 09/2002
4Leukemia
01/2022 - 09/2008
4Carcinogenesis
12/2020 - 02/2002
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022 - 03/2016
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 03/2012
3Adenoma (Adenomas)
10/2017 - 09/2002
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2021 - 10/2013
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
11/2014 - 04/2005
2Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2012 - 06/2010
2Aberrant Crypt Foci
03/2011 - 05/2008
2Atherosclerotic Plaque (Atheroma)
09/2010 - 10/2002
2Burkitt Lymphoma (Burkitt's Lymphoma)
06/2010 - 06/2009
2X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency)
01/2007 - 11/2003
2Carcinoma (Carcinomatosis)
08/2006 - 09/2002
2Chronic Renal Insufficiency
03/2006 - 02/2002
2Fibrosis (Cirrhosis)
03/2006 - 02/2002
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2003 - 03/2002
1Polyneuropathies (Polyneuropathy)
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Peripheral Nervous System Diseases (PNS Diseases)
01/2018
1Hyperplasia
10/2013
1Molluscum Contagiosum
10/2013
1Shock
01/2013
1Lymphocytosis
03/2012
1Lymphadenopathy
03/2012
1Bone Diseases (Bone Disease)
11/2011
1Thrombosis (Thrombus)
09/2010
1Colonic Neoplasms (Colon Cancer)
01/2010
1Hematologic Neoplasms (Hematological Malignancy)
06/2009
1Plasma Cell Neoplasms
04/2008
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2007
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2006

Drug/Important Bio-Agent (IBA)

5ibrutinibIBA
01/2022 - 03/2012
5ChemokinesIBA
12/2021 - 01/2007
5Syndecan-1 (Syndecan 1)IBA
01/2021 - 02/2002
5Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2020 - 09/2002
5Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2020 - 02/2002
4IntegrinsIBA
01/2022 - 01/2003
4LigandsIBA
12/2020 - 12/2010
4CateninsIBA
01/2019 - 03/2011
4beta CateninIBA
09/2008 - 09/2002
3B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
01/2022 - 04/2005
3Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 03/2012
3Immunoglobulin M (IgM)IBA
01/2022 - 03/2002
3Proteins (Proteins, Gene)FDA Link
01/2020 - 01/2003
3CytokinesIBA
01/2019 - 01/2013
3Protein Isoforms (Isoforms)IBA
10/2017 - 03/2002
3Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
05/2013 - 02/2002
3AntigensIBA
05/2013 - 07/2002
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2013 - 02/2002
3Glycoproteins (Glycoprotein)IBA
03/2006 - 02/2002
2ParaproteinsIBA
01/2022 - 01/2018
2Heparitin Sulfate (Heparan Sulfate)IBA
12/2021 - 01/2010
2Transcription Factors (Transcription Factor)IBA
01/2020 - 09/2006
2Phosphotransferases (Kinase)IBA
01/2020 - 10/2017
2ErbB Receptors (EGF Receptor)IBA
10/2019 - 10/2017
2Forkhead Transcription Factors (Forkhead Box Proteins)IBA
01/2017 - 11/2014
2Amino AcidsFDA Link
01/2017 - 04/2005
2Pharmaceutical PreparationsIBA
03/2012 - 07/2002
2Hyaluronic Acid (Hyaluronan)IBA
09/2010 - 03/2006
2MicroRNAs (MicroRNA)IBA
06/2010 - 06/2009
2TCF Transcription FactorsIBA
09/2008 - 09/2002
2HGF activatorIBA
01/2006 - 10/2004
2Immunoglobulins (Immunoglobulin)IBA
04/2005 - 01/2003
2Immunoglobulin G (IgG)IBA
04/2005 - 03/2002
2Immunoglobulin A (IgA)IBA
01/2003 - 02/2002
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1ixazomibIBA
01/2022
1Proteasome InhibitorsIBA
01/2022
1Chemokine CXCL12IBA
12/2021
1src-Family KinasesIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
10/2017
1tyrosine receptor (receptor, tyrosine)IBA
10/2017
1Proto-Oncogene Proteins c-metIBA
10/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1idelalisibIBA
03/2016
1Immunoglobulin E (IgE)IBA
10/2013
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2012
1Fibronectins (Fibronectin)IBA
03/2012
1Cadherins (E-Cadherin)IBA
11/2011
1CollagenIBA
09/2010
1Matrix Metalloproteinases (MMPs)IBA
09/2010
1LipidsIBA
09/2010
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
09/2010
1EpitopesIBA
01/2010
1SurvivinIBA
06/2009
1Monomeric GTP-Binding ProteinsIBA
04/2008
1Phospholipase C gammaIBA
01/2007
1DNA (Deoxyribonucleic Acid)IBA
10/2006
1Messenger RNA (mRNA)IBA
08/2006

Therapy/Procedure

6Therapeutics
01/2022 - 10/2017
1Precision Medicine
08/2015
1Hematopoietic Stem Cell Transplantation
10/2013